Cargando…
'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?
Proton pump inhibitors (PPIs) are widely used though an association with hypomagnesaemia and hypocalcaemia has only been described since 2006. Patients typically present after years of stable dosing with musculoskeletal, neurological or cardiac arrhythmic symptoms, but it is likely that many cases a...
Autores principales: | Atkinson, Nathan S. S., Reynolds, D. John M., Travis, Simon P. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479737/ https://www.ncbi.nlm.nih.gov/pubmed/26130997 http://dx.doi.org/10.5217/ir.2015.13.3.227 |
Ejemplares similares
-
Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019) -
Hypomagnesaemia associated with long-term use of proton pump inhibitors
por: Toh, James Wei Tatt, et al.
Publicado: (2015) -
The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
por: Tai, Yong Ting, et al.
Publicado: (2020) -
Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015) -
Iron Lemonade
Publicado: (1887)